Peptides Peptide Guides
Complete guides covering benefits, dosing protocols, side effects, and what to expect from popular peptides.
10 articles
Tesofensine: Benefits, Dosage, Side Effects & What the Trials Really Show (2026)
Tesofensine produced 10.6% weight loss in trial — the biggest number in oral appetite drugs. What that trial actually was, the caution its journal later attached to it, the phase 3 nobody cites, and why the appetite effect fades by week 24.
PNC-27 Peptide: What the Research Actually Shows (2026)
PNC-27 is designed to bind HDM-2 in cancer cell membranes and cause necrosis. That work is real and entirely confined to the lab. What has been demonstrated, what has not, and why it is not a cancer treatment.
Klotho Peptide: Benefits, Dosage & Why One Vial Is 1/40th of the Only Dose That Worked (2026)
Klotho peptide examined: the mouse lifespan data, the primate memory study converted into vials, what is really in the $499 fusion protein, the two human gene trials, and why the online 10 mcg protocol is 1/80th of the dose that worked.
Oral Peptides: Which Peptides Actually Work Without Injections (2026)
Oral and needle-free peptides explained: which peptides survive the gut, why most do not, sublingual vs capsule vs liquid drops, and how to buy oral research peptides safely.
BPC-157: Benefits, Dosage, Side Effects & 2026 Guide
BPC-157 benefits, mechanism, dosage, side effects, TB-500 stacking, FDA 2026 reclassification, and where to buy legally in 2026.
GHRP-6 vs GHRP-2 Peptide: Benefits, Dosage & Side Effects (2026)
GHRP-6 and GHRP-2 are the original ghrelin-receptor growth hormone peptides. Full comparison of benefits, side effects, dosage, mechanism, stacking, and how they stack up against ipamorelin in 2026.
KPV Peptide: Benefits, Dosing, Side Effects and Gut Uses
KPV peptide guide covering gut inflammation, skin uses, oral vs subcutaneous dosing, reconstitution units, side effects, stacks with BPC-157, and the updated 2026 FDA compounding status.
Peptide Clinical Trial Data: Every Result in One Place
70+ clinical trials compiled with exact numbers. Weight loss percentages, A1c reductions, cardiovascular outcomes, side effect rates, sample sizes, and journal citations for every major peptide and GLP-1 drug.
GLOW Peptide for Skin: What It Does and What Changes First
How the GLOW blend works on skin at the cellular level. Timeline of changes, best use cases, post-procedure synergy, and how it compares to retinoids.
Brenipatide: Lilly's Monthly GLP-1 That Isn't About Weight Loss
Brenipatide (LY-3537031) is a once-monthly GLP-1/GIP agonist from Eli Lilly targeting addiction, depression, and psychiatric conditions, not obesity. Here's what it is and why it matters.